Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.66% |
| 2 | Healthcare | 3.16% |
| 3 | Industrials | 2.01% |
| 4 | Financials | 1.98% |
| 5 | Consumer Discretionary | 1.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CURO
8826
CALL
DELISTED
CURO Group Holdings Corp.
CURO
| $321K | ﹤0.01% |
22,400
+9,000
| +67% | +$82.8K |
|
8827
Anavex Life Sciences
AVXL
$310M
| $320K | ﹤0.01% |
59,384
-8,803
| -13% | -$46.4K |
|
8828
PUT
Xcel Energy
XEL
$48.8B
| $320K | ﹤0.01% |
4,800
-6,700
| -58% | -$467K |
|
|
SYRS
8829
CALL
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $320K | ﹤0.01% |
+2,950
| New | +$269K |
|
|
CYBE
8830
DELISTED
Cyberoptics Corp
CYBE
| $320K | ﹤0.01% |
+14,108
| New | +$401K |
|
8831
VirnetX Holding Corp
VHC
$63.1M
| $319K | ﹤0.01% |
3,167
-3,501
| -53% | -$378K |
|
|
AY
8832
CALL
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $319K | ﹤0.01% |
8,400
-16,200
| -66% | -$536K |
|
|
FRGI
8833
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $319K | ﹤0.01% |
27,990
+11,365
| +68% | +$125K |
|
8834
PUT
GFL Environmental
GFL
$14.9B
| $318K | ﹤0.01% |
+10,900
| New | +$267K |
|
8835
ARK Israel Innovative Technology ETF
IZRL
$141M
| $318K | ﹤0.01% |
+10,717
| New | +$290K |
|
8836
Mueller Industries
MLI
$15.2B
| $318K | ﹤0.01% |
36,188
-310,236
| -90% | -$2.48M |
|
8837
Metallus
MTUS
$898M
| $318K | ﹤0.01% |
68,108
-14,718
| -18% | -$66.6K |
|
8838
CALL
Arch Capital
ACGL
$33.6B
| $317K | ﹤0.01% |
8,800
-16,700
| -65% | -$548K |
|
8839
PUT
Archrock
AROC
$5.8B
| $317K | ﹤0.01% |
36,600
+11,000
| +43% | +$80.3K |
|
|
AVNS
8840
CALL
DELISTED
Avanos Medical
AVNS
| $317K | ﹤0.01% |
6,900
-700
| -9% | -$29.1K |
|
8841
CALL
UFP Industries
UFPI
$5.19B
| $317K | ﹤0.01% |
5,700
-900
| -14% | -$49.4K |
|
8842
PUT
Viavi Solutions
VIAV
$9.66B
| $317K | ﹤0.01% |
21,200
-9,500
| -31% | -$126K |
|
|
CNST
8843
PUT
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $317K | ﹤0.01% |
+11,000
| New | +$277K |
|
|
AGEN
8844
Agenus
AGEN
$290M
| $316K | ﹤0.01% |
5,065
-9,038
| -64% | -$671K |
|
8845
PUT
Avnet
AVT
$7.92B
| $316K | ﹤0.01% |
9,000
-5,400
| -38% | -$160K |
|
|
8846
PUT
Anavex Life Sciences
AVXL
$310M
| $316K | ﹤0.01% |
58,600
+38,800
| +196% | +$204K |
|
8847
PUT
BlueLinx
BXC
$706M
| $316K | ﹤0.01% |
10,800
-4,300
| -28% | -$110K |
|
|
GNTY
8848
DELISTED
Guaranty Bancshares
GNTY
| $316K | ﹤0.01% |
+11,623
| New | +$308K |
|
8849
PUT
Mustang Bio
MBIO
$4.55M
| $316K | ﹤0.01% |
111
+4
| +4% | +$9.56K |
|
8850
Nuveen ESG Large-Cap Value ETF
NULV
$2.28B
| $316K | ﹤0.01% |
+9,590
| New | +$300K |
|
Similar funds
Citadel Advisors's Q4 2020 Portfolio in Review
As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.
- Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
- Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.